Personal CFO Solutions LLC Makes New Investment in Tenet Healthcare Corporation (NYSE:THC)

Personal CFO Solutions LLC bought a new stake in Tenet Healthcare Corporation (NYSE:THC - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 1,672 shares of the company's stock, valued at approximately $225,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA purchased a new stake in shares of Tenet Healthcare during the 1st quarter worth $26,000. Wayfinding Financial LLC purchased a new stake in shares of Tenet Healthcare during the 1st quarter worth $28,000. Colonial Trust Co SC boosted its position in shares of Tenet Healthcare by 85.7% during the 4th quarter. Colonial Trust Co SC now owns 247 shares of the company's stock worth $31,000 after purchasing an additional 114 shares in the last quarter. GeoWealth Management LLC boosted its position in shares of Tenet Healthcare by 39.8% during the 4th quarter. GeoWealth Management LLC now owns 295 shares of the company's stock worth $37,000 after purchasing an additional 84 shares in the last quarter. Finally, Versant Capital Management Inc raised its stake in shares of Tenet Healthcare by 46.2% during the 1st quarter. Versant Capital Management Inc now owns 718 shares of the company's stock worth $97,000 after buying an additional 227 shares during the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Wall Street Zen raised Tenet Healthcare from a "hold" rating to a "buy" rating in a research note on Sunday, June 15th. Royal Bank Of Canada boosted their target price on shares of Tenet Healthcare from $183.00 to $189.00 and gave the company an "outperform" rating in a research note on Wednesday, April 30th. Guggenheim started coverage on shares of Tenet Healthcare in a research note on Wednesday, April 9th. They issued a "buy" rating and a $165.00 target price for the company. Morgan Stanley boosted their target price on shares of Tenet Healthcare from $175.00 to $210.00 and gave the company an "overweight" rating in a research note on Monday, June 9th. Finally, Wells Fargo & Company raised shares of Tenet Healthcare from an "equal weight" rating to an "overweight" rating and boosted their target price for the company from $150.00 to $195.00 in a research note on Thursday, May 29th. Three analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $183.94.

Insider Buying and Selling at Tenet Healthcare

In other Tenet Healthcare news, Director Richard W. Fisher sold 836 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The stock was sold at an average price of $173.16, for a total value of $144,761.76. Following the completion of the transaction, the director owned 11,292 shares in the company, valued at $1,955,322.72. This represents a 6.89% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Thomas W. Arnst sold 9,786 shares of the company's stock in a transaction that occurred on Wednesday, May 21st. The stock was sold at an average price of $166.00, for a total value of $1,624,476.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 54,121 shares of company stock worth $8,846,305. Company insiders own 0.81% of the company's stock.

Tenet Healthcare Trading Up 1.4%

Shares of NYSE THC traded up $2.46 on Thursday, reaching $173.86. 850,607 shares of the company traded hands, compared to its average volume of 1,562,403. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.23. Tenet Healthcare Corporation has a fifty-two week low of $109.82 and a fifty-two week high of $178.76. The stock has a market capitalization of $16.15 billion, a PE ratio of 11.50, a P/E/G ratio of 1.26 and a beta of 1.64. The company has a 50 day moving average of $164.82 and a 200 day moving average of $141.82.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Tuesday, April 29th. The company reported $4.36 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.11 by $1.25. Tenet Healthcare had a return on equity of 22.58% and a net margin of 7.09%. The business had revenue of $5.22 billion during the quarter, compared to analysts' expectations of $5.15 billion. During the same quarter in the previous year, the business earned $3.22 EPS. The company's revenue for the quarter was down 2.5% on a year-over-year basis. On average, equities research analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.